UOC
LUXAU

UBS O'Connor’s Lux Health Tech Acquisition Corp. Units LUXAU Stock Holding History

UBS O'Connor’s Portfolio LUXAU Stock Details LUXAU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-228,125
Closed -$2.68M – 1011
2020
Q4 		$2.68M Buy
+228,125
New +$2.45M 0.05% 324

Other funds holding LUXAU

DCP
D1 Capital Partners New York $11.2B AUM 15.78% 1-Year Est. Return
BCM
BlueCrest Capital Management St Helier, Jersey $1.69B AUM 20.01% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
BP
BBR Partners New York $1.79B AUM 16.83% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS O'Connor's LUXAU Position: Q1 2021 in Review

UBS O'Connor sold out of Lux Health Tech Acquisition Corp. Units (LUXAU) in Q1 2021, closing a stake of 228,125 shares — an estimated $2.68M sold.

UBS O'Connor first reported a position in LUXAU in Q4 2020 and held it in 1 quarter. The position peaked at $2.68M in Q4 2020. 24 funds tracked by Wall St. Rank hold LUXAU as of Q1 2021.

  • UBS O'Connor reported no remaining Lux Health Tech Acquisition Corp. Units position as of Q1 2021 after selling out during the quarter.
  • UBS O'Connor sold 228,125 Lux Health Tech Acquisition Corp. Units shares in Q1 2021, an estimated $2.68M.
  • UBS O'Connor first reported a position in Lux Health Tech Acquisition Corp. Units in Q4 2020 and held it in 1 quarter.
  • UBS O'Connor's Lux Health Tech Acquisition Corp. Units position peaked at $2.68M in Q4 2020.
  • 24 funds tracked by Wall St. Rank held Lux Health Tech Acquisition Corp. Units as of Q1 2021.

Based on UBS O'Connor's 13F filing for Q1 2021, filed 14 May 2021.